DBV Technologies DBVT
NASDAQ DBVT
$13.52 -0.18 (-1.35%)
As of: Sep 4, 2026 · 2:27 PM EDT

DBV Technologies (DBVT) EPS (Basic) Growth (5y) (2025 - 2026)

Analysis

DBV Technologies (DBVT) EPS (Basic) Growth (5y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 DBV Technologies 5.86 Bn 5.68 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.94%
Mar 31, 2026 27.01%
Dec 31, 2025 15.14%
Sep 30, 2025 15.55%
Jun 30, 2025 18.72%
Mar 31, 2025 19.68%